1. |
Fu J, Li Y, Zhang H, et al. Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease. J Thorac Cardiovasc Surg, 2021, 162(1): 72-82.
|
2. |
Chen SW, Chen CY, Chien-Chia Wu V, et al. Mitral valve repair versus replacement in patients with rheumatic heart disease. J Thorac Cardiovasc Surg, 2022, 164(1): 57-67.
|
3. |
Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med, 2017, 377(8): 713-722.
|
4. |
Yang S, Hu H, Lin M, et al. Medium long-term follow-up outcomes of BalMedic® bovine pericardial bioprosthetic valve in the mitral position. J Thorac Dis, 2021, 13(6): 3652-3659.
|
5. |
Fishbein GA, Fishbein MC. Mitral valve pathology. Current Cardiology Reports, 2019, 21(7): 61.
|
6. |
Beaton A, Okello E, Rwebembera J, et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med, 2022, 386(3): 230-240.
|
7. |
de Loizaga SR, Beaton AZ, Nascimento BR, et al. Diagnosing rheumatic heart disease: Where are we now and what are the challenges? Expert Rev Cardiovasc Ther, 2021, 19(9): 777-786.
|
8. |
Dougherty S, Okello E, Mwangi J, et al. Rheumatic heart disease: JACC Focus Seminar 2/4. J Am Coll Cardiol, 2023, 81(1): 81-94.
|
9. |
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol, 2019, 74(20): 2529-2532.
|
10. |
Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: A compass for global action. J Am Coll Cardiol, 2020, 76(25): 2980-2981.
|
11. |
Liao YB, Wang TKM, Wang MTM, et al. Meta-analysis of mitral valve repair versus replacement for rheumatic mitral valve disease. Heart Lung Circ, 2022, 31(5): 705-710.
|
12. |
Uchino G, Murakami H, Mukohara N, et al. Very-long-term outcomes of mechanical valves in mitral position focusing on valve-related complications. Interact Cardiovasc Thorac Surg, 2022, 35(2): ivac146.
|
13. |
Weich H, Herbst P, Smit F, et al. Transcatheter heart valve interventions for patients with rheumatic heart disease. Front Cardiovasc Med, 2023, 10: 1234165.
|
14. |
Simpson MT, Kachel M, Neely RC, et al. Rheumatic heart disease in the developing world. Struct Heart, 2023, 7(6): 100219.
|
15. |
Luo T, Meng X. Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy. J Thorac Dis, 2021, 13(5): 2933-2941.
|
16. |
中华医学会胸心血管外科分会瓣膜病外科学组. 风湿性二尖瓣病变外科治疗指征中国专家共识. 中华胸心血管外科杂志, 2022, 38(3): 132-137.
|
17. |
Luo T, Meng X, Yan Z, et al. Commissuroplasty as a main operative technique in rheumatic mitral valve repair: Surgical experiences and mid-term results. Heart Lung Circ, 2020, 29(6): 940-948.
|
18. |
韩仲仪, 谢恩泽华, 杨秀滨. 风湿性二尖瓣狭窄的瓣膜外科修复研究进展. 中国胸心血管外科临床杂志, 2023, 30(10): 1513-1518.
|
19. |
Wunderlich NC, Dalvi B, Ho SY, et al. Rheumatic mitral valve stenosis: Diagnosis and treatment options. Curr Cardiol Rep, 2019, 21(3): 14.
|
20. |
Harb SC, Griffin BP. Mitral valve disease: A comprehensive review. Curr Cardiol Rep, 2017, 19(8): 73.
|
21. |
Jiang Y, Wang C, Li G, et al. Clinical outcomes following surgical mitral valve repair or replacement in patients with rheumatic heart disease: A meta-analysis. Ann Transl Med, 2021, 9(3): 204.
|